mcneil-p.c.c., Inc. v. Bristol-Myers Squibb Company

U.S. Court of Appeals, Second Circuit · Decided 1991-07-16

Cited by 126 later decision(s) in our corpus · see the citation network in Lexace

From the opinion

ALTIMARI, Circuit Judge: The dispute in the underlying action centers upon an advertising campaign launched by defendant-appellant Bristol-Myers Squibb Company (“Bristol-Myers”), proclaiming that Aspirin-Free Excedrin (“AF Excedrin”), an over-the-counter (“OTC”) analgesic it manufacturers, relieves pain better than Extra-Strength Tylenol (“ES Tylenol”), an OTC analgesic manufa…

Read the full opinion (source) ↗

Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Citation figures are counts of later citing opinions in our corpus and may be incomplete; always read and Shepardize the full opinion before relying on it.